首页> 外文期刊>Der Pharmacia Lettre >Formulation and evaluation of rizatriptan benzoate orodispersible tablets
【24h】

Formulation and evaluation of rizatriptan benzoate orodispersible tablets

机译:利扎曲普坦苯甲酸酯口腔分散片的配制与评价

获取原文
           

摘要

Oral disintegrating tablets have emerged as an alternative to the conventional oral dosage forms to improve the patient compliance. Due to problem in swallowing ability with age, the paediatric and geriatric patients complain of difficulty to take conventional solid dosage forms. The ODT’s are solid dosage forms that dissolve or disintegrate rapidly in the oral cavity. This results in solution or suspension without the need of water. The main objective of this work is to formulate and evaluate Rizatriptan Benzoate ODT’s using different concentration of super disintegrating agents like croscarmellose , Sodium Starch Glycolate (SSG),Crospovidone.Tablets were prepared by direct compression method and evaluated for hardness, thickness, friability, disintegration time, and percentage of drug release.. The results indicated that formulation prepared with Crospovidone was found to be optimised which provides maximum drug release (100%) and minimum disintegration time (less than 10 second).
机译:口服崩解片剂已经出现,成为常规口服剂型的替代品,以改善患者的依从性。由于随年龄的吞咽能力问题,小儿和老年患者抱怨难以服用常规固体剂型。 ODT是固体剂型,可在口腔中快速溶解或崩解。这导致溶液或悬浮液而无需水。这项工作的主要目的是使用不同浓度的超崩解剂如交联羧甲基纤维素,乙醇酸淀粉钠(SSG)和交联维维酮来配制和评估利扎曲普坦苯甲酸酯ODT。通过直接压片法制备片剂并评估其硬度,厚度,易碎性,崩解性结果表明,用Crospovidone制备的制剂已被优化,可提供最大的药物释放(100%)和最短的崩解时间(少于10秒)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号